Gadoteridol

CAS No. 120066-54-8

Gadoteridol( SQ-32692 | Gd-HP-DO3A | ProHance )

Catalog No. M27077 CAS No. 120066-54-8

Gadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 48 Get Quote
50MG 65 Get Quote
100MG 95 Get Quote
200MG 140 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Gadoteridol
  • Note
    Research use only, not for human use.
  • Brief Description
    Gadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.
  • Description
    Gadoteridolused in the imaging of the central nervous system that is used for a gadolinium-based MRI contrast agent.
  • In Vitro
    ——
  • In Vivo
    Gadoteridol (1 mM; intracerebral injection; once) enhances distribution of rAAV1 in the rat hippocampus. Animal Model:Sprague-Dawley rats (3 -5 months) Dosage:1 mM/rat Administration:Intracerebral injection, once, co-infused with rAAV1 or AAV5Result:Increased the transduction efficiency of AAV1 but not AAV5.
  • Synonyms
    SQ-32692 | Gd-HP-DO3A | ProHance
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    120066-54-8
  • Formula Weight
    557.68
  • Molecular Formula
    C17H28GdN4O7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : ≥ 280 mg/mL (502.08 mM))
  • SMILES
    [Gd+3]1234567[N]8(CC[N]1(CC[N]2(CC[N]3(CC8)CC([O-]4)=O)CC([O-]5)=O)CC([O-]6)=O)CC(C)O7
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cuendet M, et al. Antitumor activity of bruceantin: an old drug with new promise. J Nat Prod. 2004 Feb;67(2):269-72.
molnova catalog
related products
  • Cyclic MKEY

    MKEY, a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, has been shown to protect against atherosclerosis and aortic aneurysm formation by mediating inflammation, but whether it modulates neuroinflammation and brain injury has not been studied.

  • BMS-502

    BMS-502 is a potent dual inhibitor of diacylglycerol kinase (DGK) α and ζ that induces immune responses in human and mouse T cells and blocks intracellular checkpoint signaling in T cells.

  • Prolactin Releasing ...

    Prolactin Releasing Peptide (1-31), human is a high affinity GPR10 ligand that cause the release of the prolactin. Human and rat Prolactin Releasing Peptide (1-31) binds to GPR10 with Kis of 1.03 and 0.33 nM, respectively.Prolactin-releasing peptide is a specific prolactin releasing peptide.